These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12942141)

  • 1. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.
    Gould TD; Chen G; Manji HK
    Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
    Alimohamad H; Rajakumar N; Seah YH; Rushlow W
    Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium.
    O'Brien WT; Harper AD; Jové F; Woodgett JR; Maretto S; Piccolo S; Klein PS
    J Neurosci; 2004 Jul; 24(30):6791-8. PubMed ID: 15282284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus.
    Kaidanovich-Beilin O; Milman A; Weizman A; Pick CG; Eldar-Finkelman H
    Biol Psychiatry; 2004 Apr; 55(8):781-4. PubMed ID: 15050857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells.
    Laeng P; Pitts RL; Lemire AL; Drabik CE; Weiner A; Tang H; Thyagarajan R; Mallon BS; Altar CA
    J Neurochem; 2004 Oct; 91(1):238-51. PubMed ID: 15379904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
    Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
    Chen G; Huang LD; Jiang YM; Manji HK
    J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain.
    Lesort M; Greendorfer A; Stockmeier C; Johnson GV; Jope RS
    J Neural Transm (Vienna); 1999; 106(11-12):1217-22. PubMed ID: 10651115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
    Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
    Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase 3beta suppresses coxsackievirus-induced cytopathic effect and apoptosis via stabilization of beta-catenin.
    Yuan J; Zhang J; Wong BW; Si X; Wong J; Yang D; Luo H
    Cell Death Differ; 2005 Aug; 12(8):1097-106. PubMed ID: 15905881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors.
    Gould TD; Einat H; O'Donnell KC; Picchini AM; Schloesser RJ; Manji HK
    Neuropsychopharmacology; 2007 Oct; 32(10):2173-83. PubMed ID: 17299510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of inhibition of glycogen synthase kinase-3 on cardiac hypertrophy during acute pressure overload.
    Tateishi A; Matsushita M; Asai T; Masuda Z; Kuriyama M; Kanki K; Ishino K; Kawada M; Sano S; Matsui H
    Gen Thorac Cardiovasc Surg; 2010 Jun; 58(6):265-70. PubMed ID: 20549454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium.
    De Sarno P; Li X; Jope RS
    Neuropharmacology; 2002 Dec; 43(7):1158-64. PubMed ID: 12504922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycogen synthase kinase-3β prevents sympathetic hyperinnervation in infarcted rats.
    Lee TM; Lin SZ; Chang NC
    Exp Biol Med (Maywood); 2015 Jul; 240(7):979-92. PubMed ID: 25576342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
    Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
    Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.